150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, and
0.1% SDS) supplemented with proteinase inhibitors. Tissue or cell
lysates were cleared and separated by 10% SDS-PAGE and transferred to
polyvinylidene fluoride (PVDF, Millipore) or Hybond nitrocellulose (GE
Healthcare) membranes, following standard procedures. Blots were probed with the
primary antibodies which were then detected with HRP-conjugated secondary
antibodies (BD biosciences) and SuperSignal substrates (Thermo Scientific).
Enhanced chemiluminescent (ECL) substrate (Pierce, Rockford, IL USA) and
CL-XPosure film (Thermo Scientific) were used for detection. The following
primary antibodies were used: GORAB, 1:1,000 (Proteintech); β-actin,
1:1,000 (Santa Cruz); GLI1, 1:250 (clone V812, Cell Signaling); GLI3 (1
µg/ml, Cell Signaling). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
or β-actin was used as a loading control. Quantification was performed
with densitometry and ImageJ software (1.43u, NIH).